Round Type
Series B
BostonBiotechnologyHealth CareTherapeuticsDescription
Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system (CNS) diseases using the company’s proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform, today announced an expansion of its Series B funding round with an additional close of $51 million, bringing the total Series B financing to $116 million. The financing will support upcoming clinical trials focused on Parkinson’s disease, Amyotrophic Lateral Sclerosis (ALS), and schizophrenia.
Quick answer
Cerevance raised an undisclosed amount in a Series B round, dated February 13, 2023. Cerevance is based in Boston, Massachusetts, United States.
- How much did Cerevance raise?
- Cerevance raised an undisclosed amount in a Series B round on February 13, 2023.
- What does Cerevance do?
- Cerevance is focused on the development of treatments for central nervous system (CNS) disorders, with a focus on neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral..
- Where is Cerevance based and how big is it?
- Cerevance is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Cerevance?
- Fundz holds 1 contact at Cerevance. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Cerevance that raised within 45 days of this round, from Fundz verified event records.
- Trobix Bio raised $3M (Seed) on March 30, 2023.
- Arialys Therapeutics raised $10M (Series A) on March 30, 2023.
- Milestone Pharmaceuticals raised $125M on March 28, 2023.
- Cora Therapeutics raised $1M (Seed) on March 27, 2023.
- Flare Therapeutics raised $123M (Series B) on March 22, 2023.
- Alpha Cognition raised $1.3M (Seed) on March 15, 2023.
Who to call at Cerevance, and when
A new round usually means Cerevance is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cerevance raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cerevance, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cerevance. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cerevance raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCerevance raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.